166 related articles for article (PubMed ID: 11122809)
1. Clinical implications of biomarkers in head and neck cancer.
Koch WM
Curr Oncol Rep; 1999; 1(2):129-37. PubMed ID: 11122809
[TBL] [Abstract][Full Text] [Related]
2. Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma.
Wang SS; Cen X; Liang XH; Tang YL
Oncotarget; 2017 Feb; 8(6):10650-10661. PubMed ID: 27788497
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of head and neck squamous cell carcinoma.
Feldman R; Gatalica Z; Knezetic J; Reddy S; Nathan CA; Javadi N; Teknos T
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E1625-38. PubMed ID: 26614708
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic factors for head and neck cancer].
Fujieda S
Gan To Kagaku Ryoho; 2001 Apr; 28(4):440-7. PubMed ID: 11329776
[TBL] [Abstract][Full Text] [Related]
5. Effective Biomarkers and Radiation Treatment in Head and Neck Cancer.
Ow TJ; Pitts CE; Kabarriti R; Garg MK
Arch Pathol Lab Med; 2015 Nov; 139(11):1379-88. PubMed ID: 26046489
[TBL] [Abstract][Full Text] [Related]
6. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
van Ginkel JH; Huibers MMH; van Es RJJ; de Bree R; Willems SM
BMC Cancer; 2017 Jun; 17(1):428. PubMed ID: 28629339
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs Involvement in Radioresistance of Head and Neck Cancer.
Ahmad P; Sana J; Slavik M; Slampa P; Smilek P; Slaby O
Dis Markers; 2017; 2017():8245345. PubMed ID: 28325958
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of microvessel density and p53 expression on the locoregional metastasis and survival of the patients with head and neck squamous cell carcinoma.
de Oliveira MV; Pereira Gomes EP; Pereira CS; de Souza LR; Barros LO; Mendes DC; Guimarães AL; De Paula AM
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):444-51. PubMed ID: 23343952
[TBL] [Abstract][Full Text] [Related]
9. Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report.
Merhi M; Raza A; Inchakalody VP; Nashwan AJJ; Allahverdi N; Krishnankutty R; Uddin S; Zar Gul AR; Al Homsi MU; Dermime S
Front Immunol; 2018; 9():1769. PubMed ID: 30108590
[TBL] [Abstract][Full Text] [Related]
10. Emerging biomarkers in head and neck cancer in the era of genomics.
Kang H; Kiess A; Chung CH
Nat Rev Clin Oncol; 2015 Jan; 12(1):11-26. PubMed ID: 25403939
[TBL] [Abstract][Full Text] [Related]
11. Nod-like receptors in head and neck squamous cell carcinoma.
Millrud CR; Kvarnhammar AM; Tajti J; Munck-Wikland E; Uddman R; Cardell LO
Acta Otolaryngol; 2013 Dec; 133(12):1333-44. PubMed ID: 24053487
[TBL] [Abstract][Full Text] [Related]
12. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck.
Nylander K; Dabelsteen E; Hall PA
J Oral Pathol Med; 2000 Oct; 29(9):413-25. PubMed ID: 11016683
[TBL] [Abstract][Full Text] [Related]
13. [Immunotherapeutic studies of head and neck tumors : Highlights of the 2016 ASCO Annual Meeting].
Busch CJ; Laban S; Knecht R; Hoffmann TK
HNO; 2016 Oct; 64(10):708-16. PubMed ID: 27604282
[TBL] [Abstract][Full Text] [Related]
14. Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck.
Vlatković N; El-Fert A; Devling T; Ray-Sinha A; Gore DM; Rubbi CP; Dodson A; Jones AS; Helliwell TR; Jones TM; Boyd MT
Cancer; 2011 Jul; 117(13):2939-50. PubMed ID: 21692053
[TBL] [Abstract][Full Text] [Related]
15. Squamous carcinoma of the head and neck: molecular mechanisms and potential biomarkers.
Rose BR; Thompson CH; Tattersall MH; O'Brien CJ; Cossart YE
Aust N Z J Surg; 2000 Aug; 70(8):601-6. PubMed ID: 10945556
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.
Gollin SM
Genes Chromosomes Cancer; 2014 Dec; 53(12):972-90. PubMed ID: 25183546
[TBL] [Abstract][Full Text] [Related]
17. Circulating markers in squamous cell carcinoma of the head and neck: a review.
Rassekh CH; Johnson JT; Eibling DE
Eur J Cancer B Oral Oncol; 1994 Jan; 30B(1):23-8. PubMed ID: 9135969
[TBL] [Abstract][Full Text] [Related]
18. Combining factors on protein and gene level to predict radioresponse in head and neck cancer cell lines.
Farnebo L; Jerhammar F; Ceder R; Grafström RC; Vainikka L; Thunell L; Grénman R; Johansson AC; Roberg K
J Oral Pathol Med; 2011 Nov; 40(10):739-46. PubMed ID: 21481002
[TBL] [Abstract][Full Text] [Related]
19. The role of HOX genes in head and neck squamous cell carcinoma.
Platais C; Hakami F; Darda L; Lambert DW; Morgan R; Hunter KD
J Oral Pathol Med; 2016 Apr; 45(4):239-47. PubMed ID: 26661059
[TBL] [Abstract][Full Text] [Related]
20. VRK1 signaling pathway in the context of the proliferation phenotype in head and neck squamous cell carcinoma.
Santos CR; Rodríguez-Pinilla M; Vega FM; Rodríguez-Peralto JL; Blanco S; Sevilla A; Valbuena A; Hernández T; van Wijnen AJ; Li F; de Alava E; Sánchez-Céspedes M; Lazo PA
Mol Cancer Res; 2006 Mar; 4(3):177-85. PubMed ID: 16547155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
